Nerissa Kreher Tiburio's guest appearances

Nerissa Kreher Tiburio

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Dr. Nerissa Kreher, Chief Medical Officer, Tiburio discusses the company's lead asset, TBR-760 as a novel treatment option for patients with non-functioning pituitary adenomas (NFPA), which are rare neuroendocrine tumors located in the pituitary gland.  She also speaks about the challenges facing patients even after surgical or radiation treatments for these pituitary tumors. @TiburioT #neuroendocrine  #pituitaryadenoma  #chiefmedicalofficer  #raredisease  #NFPA  Tiburio Therapeutics Download the PDF file of the interview here.

Dr. Nerissa Kreher, Chief Medical Officer, Tiburio discusses the company's lead asset, TBR-760 as a novel treatment option for patients with non-functioning pituitary adenomas (NFPA), which are rare neuroendocrine tumors located in the pituitary gland.  She also speaks about the challenges facing patients even after surgical or radiation treatments for these pituitary tumors. @TiburioT #neuroendocrine  #pituitaryadenoma  #chiefmedicalofficer  #raredisease  #NFPA  <a href="https://www.tiburio.com/" rel="noopener nofollow" target="_blank">Tiburio Therapeutics</a> <a href="http://empoweredpatientradio.com/novel-treatment-for-rare-neuroendocrine-diseases-with-dr-nerissa-kreher-tiburio-transcript" rel="noopener nofollow" target="_blank">Download the PDF file of the interview here.</a>

Novel Treatment for Rare Neuroendocrine Diseases with Dr. Nerissa Kreher Tiburio